Literature DB >> 12454377

Blood viscosity and platelet function in patients with obstructive sleep apnea syndrome treated with nasal continuous positive airway pressure.

W H Reinhart1, J Oswald, R Walter, M Kuhn.   

Abstract

Patients with obstructive sleep apnea syndrome (OSA) have a high incidence of cardiovascular events. We measured whole blood viscosity at high (94.5 s(-1)) and low (0.1 s(-1)) shear rate, hematocrit, fibrinogen, and platelet hemostatic function (PTA-100) at 7-8 p.m. and 7-8 a.m. in 8 controls and 13 patients, once with the established nasal continuous positive airway pressure (NCPAP) treatment and once without. OSA patients had a higher plasma viscosity (1.37+/-0.11 vs. 1.19+/-0.11 mPa.s in the evening, p<0.05) and fibrinogen (2.61+/-0.49 vs. 2.11+/-0.29 g/l, p<0.05) than controls, without diurnal difference, and similar values with or without NCPAP. Whole blood viscosity and hematocrit were similar in controls and patients before and after a night with or without NCPAP. Platelet activity was significantly higher in the morning than in the evening in controls and patients with or without NCPAP. We conclude that blood viscosity and platelet activity are similar in controls and patients with OSA on a long-term treatment with NCPAP, which is not worsened by a single night without NCPAP. The increase of plasma viscosity and fibrinogen in OSA patients as well as the general increase of platelet aggregation in the morning may contribute to the increased incidence of cardiovascular events.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12454377

Source DB:  PubMed          Journal:  Clin Hemorheol Microcirc        ISSN: 1386-0291            Impact factor:   2.375


  10 in total

Review 1.  Coagulability in obstructive sleep apnea.

Authors:  Christina Liak; M Fitzpatrick
Journal:  Can Respir J       Date:  2011 Nov-Dec       Impact factor: 2.409

2.  Day/Night rhythm of hemostatic factors in obstructive sleep apnea.

Authors:  Roland von Känel; Loki Natarajan; Sonia Ancoli-Israel; Paul J Mills; José S Loredo; Joel E Dimsdale
Journal:  Sleep       Date:  2010-03       Impact factor: 5.849

3.  Association between sleep apnea severity and blood coagulability: Treatment effects of nasal continuous positive airway pressure.

Authors:  Roland von Känel; José S Loredo; Sonia Ancoli-Israel; Joel E Dimsdale
Journal:  Sleep Breath       Date:  2006-09       Impact factor: 2.816

4.  Obstructive sleep apnea and cardiovascular disease.

Authors:  David E Green; David A Schulman
Journal:  Curr Treat Options Cardiovasc Med       Date:  2010-08

5.  Obstructive sleep apnea is the triggering factor for massive hemoptysis : Obstructive sleep apnea and hemoptysis.

Authors:  Meral Uyar; Selim Kervancioglu; Nazan Bayram; Berna Taskin-Dogan; Ayten Filiz
Journal:  Sleep Breath       Date:  2016-12-19       Impact factor: 2.816

Review 6.  Obstructive sleep apnea syndrome: coagulation anomalies and treatment with continuous positive airway pressure.

Authors:  Domenico Maurizio Toraldo; Michele De Benedetto; Egeria Scoditti; Francesco De Nuccio
Journal:  Sleep Breath       Date:  2015-07-14       Impact factor: 2.816

Review 7.  Obstructive sleep apnea syndrome: blood viscosity, blood coagulation abnormalities, and early atherosclerosis.

Authors:  Domenico Maurizio Toraldo; Francesco Peverini; Michele De Benedetto; Francesco De Nuccio
Journal:  Lung       Date:  2012-10-18       Impact factor: 2.584

Review 8.  Obstructive sleep apnoea syndrome: a new paradigm by chronic nocturnal intermittent hypoxia and sleep disruption.

Authors:  D M Toraldo; F DE Nuccio; M DE Benedetto; E Scoditti
Journal:  Acta Otorhinolaryngol Ital       Date:  2015-04       Impact factor: 2.124

Review 9.  Coagulation and Fibrinolysis in Obstructive Sleep Apnoea.

Authors:  Andras Bikov; Martina Meszaros; Esther Irene Schwarz
Journal:  Int J Mol Sci       Date:  2021-03-11       Impact factor: 5.923

10.  Pathophysiologic mechanisms of cardiovascular disease in obstructive sleep apnea syndrome.

Authors:  Carlos Zamarrón; Luis Valdés Cuadrado; Rodolfo Alvarez-Sala
Journal:  Pulm Med       Date:  2013-06-27
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.